Wernly, B.; Lichtenauer, M.; Franz, M.; Kabisch, B.; Muessig, J.; Masyuk, M.; Kelm, M.; Hoppe, U.C.; Jung, C.
Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis? Int. J. Mol. Sci. 2016, 17, 1586.
https://doi.org/10.3390/ijms17091586
AMA Style
Wernly B, Lichtenauer M, Franz M, Kabisch B, Muessig J, Masyuk M, Kelm M, Hoppe UC, Jung C.
Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis? International Journal of Molecular Sciences. 2016; 17(9):1586.
https://doi.org/10.3390/ijms17091586
Chicago/Turabian Style
Wernly, Bernhard, Michael Lichtenauer, Marcus Franz, Bjoern Kabisch, Johanna Muessig, Maryna Masyuk, Malte Kelm, Uta C. Hoppe, and Christian Jung.
2016. "Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis?" International Journal of Molecular Sciences 17, no. 9: 1586.
https://doi.org/10.3390/ijms17091586
APA Style
Wernly, B., Lichtenauer, M., Franz, M., Kabisch, B., Muessig, J., Masyuk, M., Kelm, M., Hoppe, U. C., & Jung, C.
(2016). Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis? International Journal of Molecular Sciences, 17(9), 1586.
https://doi.org/10.3390/ijms17091586
